Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure

This study has been terminated.

( A preliminary analysis of 11 patients confirmed the safety profile of NCX-1000 but did not demonstrate the efficacy required. )

Study NCT00414869 Information provided by Axcan Pharma

First Received: December 21, 2006 Last Updated: November 16, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2007
Estimated Primary Completion Date:	No date given